| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 09/28/2023 | AGIOS PHARMACEUTICALS, INC. | AGIO | Sale | Common stock | 2.2k | $24.79 | $54k | | 09/26/2023 |
| 09/26/2023 | AGIOS PHARMACEUTICALS, INC. | AGIO | Exercise | Restricted stock units | 7.5k | $0.00 | $0 | | 09/26/2023 |
| 06/30/2023 | AGIOS PHARMACEUTICALS, INC. | AGIO | Sale | Common stock | 1.6k | $28.36 | $45.3k | | 06/28/2023 |
| 06/28/2023 | AGIOS PHARMACEUTICALS, INC. | AGIO | Exercise | Performance share units | 5.4k | $0.00 | $0 | | 06/28/2023 |
| 09/26/2022 | AGIOS PHARMACEUTICALS, INC. | AGIO | Grant | Stock options (right to buy) | 118.4k | $27.88 | $3.3M | | 09/26/2022 |
| 09/26/2022 | AGIOS PHARMACEUTICALS, INC. | AGIO | Grant | Restricted stock units | 22.4k | $0.00 | $0 | | 09/26/2022 |
| 03/01/2022 | LogicBio Therapeutics, Inc. | LOGC | Grant | Stock Option (right to buy) | 112k | $0.70 | $78.4k | | 03/01/2022 |
| 01/12/2022 | LogicBio Therapeutics, Inc. | LOGC | Payment of Exercise | Common Stock | 2.2k | $2.01 | $4.4k | | 01/11/2022 |
| 01/11/2022 | LogicBio Therapeutics, Inc. | LOGC | Exercise | Restricted Stock Units | 5.9k | $0.00 | $0 | | 01/11/2022 |
| 02/23/2021 | LogicBio Therapeutics, Inc. | LOGC | Grant | Stock Option (right to buy) | 78k | $7.76 | $605.3k | | 02/23/2021 |
| 01/11/2021 | LogicBio Therapeutics, Inc. | LOGC | Grant | Stock Option (right to buy) | 195k | $8.42 | $1.6M | | 01/11/2021 |
| 01/11/2021 | LogicBio Therapeutics, Inc. | LOGC | Grant | Restricted Stock Units | 5.9k | $0.00 | $0 | | 01/11/2021 |